- Home
- SLBT vs NVGS Comparison
SLBT vs NVGS Comparison
Compare SLBT & NVGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLBT | NVGS |
|---|---|---|
| Founded | N/A | 1997 |
| Country | Taiwan | United Kingdom |
| Employees | 20 | N/A |
| Industry | | Marine Transportation |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | SLBT | NVGS |
|---|---|---|
| Price | $2.65 | $22.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | 145.3K | ★ 418.3K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.30% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.54 | $14.08 |
| 52 Week High | $6.25 | $24.36 |
Technical Indicators
Market Signals| Indicator | SLBT | NVGS |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 61.10 |
| Support Level | N/A | $17.38 |
| Resistance Level | $4.91 | $23.16 |
| Average True Range (ATR) | 0.37 | 0.60 |
| MACD | -0.14 | 0.18 |
| Stochastic Oscillator | 7.91 | 85.78 |
Price Performance
Historical ComparisonAbout SLBT SL Science Holding Limited Ordinary Shares
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). The company plays a vital role in the globalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users, and commodity traders.